Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
December 13 2021 - 4:20PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of December 2021
Commission File Number: 001-37452
CELYAD ONCOLOGY SA
(Translation of registrants name into English)
Rue Edouard
Belin 2
1435 Mont-Saint-Guibert, Belgium
(Address of principal executive offices)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Celyad Oncology SA
On December 13, 2021, Celyad Oncology SA (the Company) issued a press release, a copy of which is attached hereto as Exhibit 99.1 and
is incorporated by reference herein.
The Company presented a slide presentation at 63rd American Society of Hematology Annual Meeting and Exposition
on December 13, 2021, a copy of which is furnished to this report as Exhibit 99.2.
The information contained in this Current Report on Form 6-K, including Exhibit 99.1 and 99.2, except for the quotes of David Gilham and Filippo Petti contained in Exhibit 99.1 is hereby incorporated by reference into the Companys Registration Statements on Form F-3 (File No. 333-248464) and Form S-8 (File No. 333-220737).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
CELYAD ONCOLOGY SA
|
|
|
|
|
Date: December 13, 2021
|
|
|
|
By:
|
|
/s/ Filippo Petti
|
|
|
|
|
|
|
Filippo Petti
Chief Executive Officer and Financial Officer
|
Celyad Oncology (NASDAQ:CYAD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Celyad Oncology (NASDAQ:CYAD)
Historical Stock Chart
From Apr 2023 to Apr 2024